These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38630773)

  • 1. Validation of SCORE2 on a sample from the Russian population and adaptation for the very high cardiovascular disease risk region.
    Svinin GE; Kutsenko VA; Shalnova SA; Yarovaya EB; Imaeva AE; Balanova YA; Kapustina AV; Muromtseva GA; Drapkina OM
    PLoS One; 2024; 19(4):e0300974. PubMed ID: 38630773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of Systematic Coronary Risk Evaluation 2 (SCORE2) and SCORE2-Older Persons in the EPIC-Norfolk prospective population cohort.
    van Trier TJ; Snaterse M; Boekholdt SM; Scholte Op Reimer WJM; Hageman SHJ; Visseren FLJ; Dorresteijn JAN; Peters RJG; Jørstad HT
    Eur J Prev Cardiol; 2024 Jan; 31(2):182-189. PubMed ID: 37793098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the SCORE2 risk prediction algorithm in a Portuguese population: A new model to estimate 10-year cardiovascular disease incidence in Europe.
    Temtem M; Mendonça MI; Santos M; Sá D; Sousa F; Freitas S; Borges S; Henriques E; Rodrigues M; Soares C; Rodrigues R; Serrão M; Drumond A; Sousa AC; Palma Reis R
    Rev Port Cardiol; 2024 Aug; 43(8):437-444. PubMed ID: 38395299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCORE2 cardiovascular risk prediction models in an ethnic and socioeconomic diverse population in the Netherlands: an external validation study.
    Kist JM; Vos RC; Mairuhu ATA; Struijs JN; van Peet PG; Vos HMM; van Os HJA; Beishuizen ED; Sijpkens YWJ; Faiq MA; Numans ME; Groenwold RHH
    EClinicalMedicine; 2023 Mar; 57():101862. PubMed ID: 36864978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk prediction of cardiovascular disease in the Asia-Pacific region: the SCORE2 Asia-Pacific model.
    ; ; ; ;
    Eur Heart J; 2024 Sep; ():. PubMed ID: 39217477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe.
    SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration
    Eur Heart J; 2023 Jul; 44(28):2544-2556. PubMed ID: 37247330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the European SCORE2 models in a Canadian primary care cohort.
    Sud M; Sivaswamy A; Austin PC; Abdel-Qadir H; Anderson TJ; Khera R; Naimark DMJ; Lee DS; Roifman I; Thanassoulis G; Tu K; Wijeysundera HC; Ko DT
    Eur J Prev Cardiol; 2024 Apr; 31(6):668-676. PubMed ID: 37946603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiovascular risk assessment among patients with hypertension based on SCORE2 and SCORE-OP algorithms in black Africans].
    Yao H; Ekou A; Ehouman E; Guezo M; Soya E; Kouadio D; Touré C; Kipenge R; Koffi D; N'Guetta R
    Ann Cardiol Angeiol (Paris); 2023 Jun; 72(3):101602. PubMed ID: 37187110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the general Framingham Risk Score (FRS), SCORE2, revised PCE and WHO CVD risk scores in an Asian population.
    Kasim SS; Ibrahim N; Malek S; Ibrahim KS; Aziz MF; Song C; Chia YC; Ramli AS; Negishi K; Mat Nasir N
    Lancet Reg Health West Pac; 2023 Jun; 35():100742. PubMed ID: 37424687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe.
    SCORE2 working group and ESC Cardiovascular risk collaboration
    Eur Heart J; 2021 Jul; 42(25):2439-2454. PubMed ID: 34120177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk assessment in Portugal's primary health care system: SCORE vs. SCORE2.
    Silva C; Mendes JE; Ramos R; Gaspar A; Leal F; Mendes N
    Rev Port Cardiol; 2024 Aug; 43(8):449-455. PubMed ID: 38395300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib.
    Mulas O; Abruzzese E; Luciano L; Iurlo A; Attolico I; Castagnetti F; Galimberti S; Bonifacio M; Annunziata M; Gozzini A; Orlandi EM; Stagno F; Binotto G; Pregno P; Fozza C; Loi M; Trawinska MM; De Gregorio F; Cattaneo D; Albano F; Iezza M; Baratè C; Scaffidi L; Elena C; Giai V; Scalzulli E; Breccia M; La Nasa G; Caocci G
    Ann Hematol; 2024 Feb; 103(2):427-436. PubMed ID: 38012435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences of cardiovascular risk assessment in clinical practice using SCORE and SCORE2.
    Csenteri O; Jancsó Z; Szöllösi GJ; Andréka P; Vajer P
    Open Heart; 2022 Nov; 9(2):. PubMed ID: 36442905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the European and US guidelines for lipid-lowering therapy in primary prevention of cardiovascular disease.
    Delabays B; de La Harpe R; Vollenweider P; Fournier S; Müller O; Strambo D; Graham I; Visseren FLJ; Nanchen D; Marques-Vidal P; Vaucher J
    Eur J Prev Cardiol; 2023 Nov; 30(17):1856-1864. PubMed ID: 37290056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-aged individuals.
    Yari A; Ueda P; Lundman P; Alfredsson J; Ravn-Fischer A; Söderberg S; Yndigegn T; Hagström E; Jernberg T
    Eur J Prev Cardiol; 2024 Nov; 31(15):1890-1897. PubMed ID: 38842486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.
    SCORE2-OP working group and ESC Cardiovascular risk collaboration
    Eur Heart J; 2021 Jul; 42(25):2455-2467. PubMed ID: 34120185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of SCORE2 and SCORE2-OP risk algorithms in a Cypriot cohort.
    Nicolaides AN; Griffin M; Panayiotou AG; Tyllis T; Bond D; Georgiou N; Kyriacou E; Avraamides C; Martin RM
    Int Angiol; 2022 Dec; 41(6):492-499. PubMed ID: 36285529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiology of Arterial Hypertension in Russian Federation - Importance of Choice of Criteria of Diagnosis].
    Erina AM; Rotar OP; Solntsev VN; Shalnova SA; Deev AD; Baranova EI; Konradi OA; Boytsov SA; Shlyakhto EV
    Kardiologiia; 2019 Jun; 59(6):5-11. PubMed ID: 31242835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carotid ultrasound and systematic coronary risk assessment 2 in the prediction of cardiovascular events.
    Bao X; Xu B; Lind L; Engström G
    Eur J Prev Cardiol; 2023 Aug; 30(10):1007-1014. PubMed ID: 37159540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines.
    Mortensen MB; Tybjærg-Hansen A; Nordestgaard BG
    JAMA Cardiol; 2022 Aug; 7(8):836-843. PubMed ID: 35793078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.